In a patient with unstable angina and active melena (gastrointestinal bleeding), when and how should unfractionated heparin be administered?

Heparin Administration in Unstable Angina with Active GI Bleeding

In a patient with unstable angina and active melena, unfractionated heparin should NOT be administered until the gastrointestinal bleeding is controlled, as active uncontrolled bleeding is an absolute contraindication to heparin therapy.

Contraindication to Heparin

Unfractionated heparin is absolutely contraindicated in patients with uncontrolled active bleeding 1. The FDA label explicitly states this contraindication, with the only exception being disseminated intravascular coagulation. Active melena represents ongoing gastrointestinal hemorrhage and falls squarely into this contraindication category.

Clinical Management Algorithm

Step 1: Stabilize the GI Bleeding First

• Immediate priorities: Hemodynamic resuscitation, red blood cell transfusion at threshold of 7 g/dL 2
• Endoscopy timing: Perform within 24 hours after presentation 3, 2
• Endoscopic hemostasis: Use combination therapy (epinephrine injection plus contact thermal or mechanical therapy) for actively bleeding lesions 3
• PPI therapy: High-dose IV bolus (80 mg) followed by continuous infusion (8 mg/hour) for 72 hours post-endoscopy 3

Step 2: Manage Unstable Angina Without Heparin Initially

While bleeding is active, focus on:

• Aspirin: Continue low-dose aspirin if already on it for secondary prevention, as it should not be interrupted even during acute GI bleeding 3. If interrupted, restart within 3-5 days once hemostasis is confirmed 3
• Alternative antiplatelet therapy: If aspirin-intolerant, consider clopidogrel, prasugrel, or ticagrelor per guideline recommendations 4
• Avoid anticoagulation: Do not initiate heparin while actively bleeding

Step 3: Timing of Heparin Initiation

Resume anticoagulation only after bleeding is controlled, preferably within or soon after 7 days of the bleeding event 3. The specific timing depends on:

• Endoscopic confirmation of hemostasis: Document that bleeding has stopped
• Stable hemoglobin: No ongoing transfusion requirements
• Thromboembolic risk assessment: Balance cardiac risk against rebleeding risk

Step 4: Heparin Dosing When Appropriate

Once bleeding is controlled and heparin is deemed necessary:

• Initial bolus: 60-70 units/kg IV (maximum 5,000 units) 5
• Continuous infusion: 12-15 units/kg/hour 5
• Target aPTT: 50-70 seconds (or anti-Xa level 0.35-0.70 units/mL) 1, 5
• Monitoring: Check aPTT 6 hours after initiation and adjust accordingly

Critical Pitfalls to Avoid

Do not attempt to "balance" anticoagulation with active bleeding. The hemorrhage risk with heparin administration during active GI bleeding far outweighs any potential cardiac benefit. Fatal hemorrhages have been documented with heparin use 1.

Do not confuse this with stable patients on chronic anticoagulation. The question specifically involves active melena, which is an ongoing bleeding state requiring immediate cessation or withholding of anticoagulation.

Elderly patients (>60 years) have higher bleeding risk with heparin 1, 5, making the decision to withhold heparin during active bleeding even more critical in this population.

Alternative Considerations

If the cardiac situation is truly dire and requires immediate anticoagulation despite ongoing bleeding:

• Consider transcatheter angiographic embolization for the GI bleeding source to achieve rapid hemostasis 3
• Involve cardiology and gastroenterology for multidisciplinary risk-benefit discussion
• Have protamine sulfate immediately available (1 mg neutralizes ~100 units of heparin) 1
• Consider ICU-level monitoring

The evidence strongly supports controlling the bleeding first, as the mortality from uncontrolled hemorrhage with concurrent anticoagulation exceeds the short-term cardiac risk in most unstable angina cases.